Johnson & Johnson's consumer-health unit Kenvue made its debut on the New York Stock Exchange and jumped about 20% on Thursday. Thibaut Mongon, CEO of Kenvue, joined Cheddar News to discuss business growth goals and what lies ahead for its well-known pipeline of products, including Band-Aid, Neutrogena, Tylenol, among others.

Share:
More In Business
Volkswagen U.S. CEO Pablo Di Si Highlights Upcoming EV Line-up
German carmaker Volkswagen said it plans to introduce 25 new electric vehicle models through 2030. As that roll out begins in earnest, Pablo Di Si, president and CEO of Volkswagen Group of America, provided Cheddar News with a breakdown of what consumers can expect from the line-up.
Load More